The Valley Desk

Clinical trial reportAnnals of the rheumatic diseasesPublished

A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritis

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Annals of the rheumatic diseases
Published
Subject terms
Humans; Recurrence; Glucocorticoids; Treatment Outcome; Remission Induction; Double-Blind Method; Aged; Aged, 80 and over; Middle Aged; Female; Male; Giant Cell Arteritis
PubMed ID
41688258
Added to directory
Source checked

Report a correction or request removal